United States v. Payne

RECOMMENDED FOR FULL-TEXT PUBLICATION
Pursuant to Sixth Circuit Rule 206
File Name: 08a0324p.06
UNITED STATES COURT OF APPEALS
FOR THE SIXTH CIRCUIT
_________________
X
Plaintiff-Appellee, -
UNITED STATES OF AMERICA,
-
-
-
No. 07-5592
v.
,
>
EBEN PAYNE, -
Defendant-Appellant. -
N
Appeal from the United States District Court
for the Middle District of Tennessee at Nashville.
No. 98-00038—John T. Nixon, District Judge.
Argued: June 12, 2008
Decided and Filed: August 28, 2008
Before: NORRIS, BATCHELDER, and GIBBONS, Circuit Judges
_________________
COUNSEL
ARGUED: Craig P. Fickling, Jr., FICKLING & MADEWELL, Cookeville, Tennessee, for
Appellant. David E. Hollar, UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C.,
for Appellee. ON BRIEF: Craig P. Fickling, Jr., FICKLING & MADEWELL, Cookeville,
Tennessee, Richard B. Mazer, San Francisco, California, for Appellant. David E. Hollar, UNITED
STATES DEPARTMENT OF JUSTICE, Washington, D.C., Sunny A.M. Koshy, ASSISTANT
UNITED STATES ATTORNEY, Nashville, Tennessee, for Appellee.
_________________
OPINION
_________________
ALAN E. NORRIS, Circuit Judge. Defendant was initially indicted in 1998 along with
several co-defendents, and currently stands charged with multiple counts involving drugs, firearms,
and violence, including multiple murders. The government has filed a notice of intent to seek the
death penalty.
Since defendant’s original indictment, he has been adjudicated incompetent to stand trial.
In November 2005, doctors at the United States Medical Center for Federal Prisoners in Springfield,
Missouri (“Springfield”), the federal facility where defendant was being held, determined that he
needed to be medicated with anti-psychotic drugs for his own safety and the safety of others.
Defendant refused to ingest oral medication, however, so the medicine was injected involuntarily.
Afterwards, Springfield’s administration held a due process hearing, where it was determined that
continued involuntary medication was necessary for safety reasons.
1
No. 07-5592 United States v. Payne Page 2
In May 2006, defendant moved for an evidentiary hearing to determine whether the
government could continue to medicate him involuntarily. The motion was granted, and it is the
order resulting from that hearing that is the subject of this interlocutory appeal.
In its order, the district court ruled that, in addition to continuing to medicate defendant for
safety reasons, the government could constitutionally administer anti-psychotic drugs to defendant
in an effort to render him competent to stand trial. However, it placed a four-month limitation on
this enhanced involuntary treatment, as well as other restrictions. For the reasons that follow, the
order of the district court is affirmed.
I.
Defendant was initially indicted on March 26, 1998 on charges involving drug trafficking
and related criminal activity. Since then, the government has amended the indictment five times,
most recently on September 27, 2002. Shortly thereafter, the government filed notice of its intent
to seek the death penalty against defendant and two co-defendants.
The fifth superceding indictment includes charges that arose out of an alleged continuing
criminal enterprise and drug conspiracy carried out by a Los Angeles-based street gang. Along with
others, the defendant allegedly transported and distributed drugs, used and possessed firearms,
laundered money, and engaged in violent acts, including assault, abduction, robbery, and murder.
The charged conduct spanned a seven-year period from 1993 through September 1999, and was
conducted in several cities. Defendant has yet to be tried.
In early 2004, defendant filed a motion for an examination and hearing to determine
competency. He was monitored and tested at the Springfield facility, and on February 24, 2005, the
district court found defendant mentally incompetent to stand trial, and placed him in the custody of
the Attorney General to determine whether there was a substantial probability that in the foreseeable
future defendant would return to competency pursuant to 18 U.S.C. § 4241(d).1
1
The section provides:
(d) Determination and disposition. If, after the hearing, the court finds by a preponderance of the
evidence that the defendant is presently suffering from a mental disease or defect rendering him
mentally incompetent to the extent that he is unable to understand the nature and consequences of the
proceedings against him or to assist properly in his defense, the court shall commit the defendant to
the custody of the Attorney General. The Attorney General shall hospitalize the defendant for
treatment in a suitable facility–
(1) for such a reasonable period of time, not to exceed four months, as is necessary to determine
whether there is a substantial probability that in the foreseeable future he will attain the capacity to
permit the proceedings to go forward; and
(2) for an additional reasonable period of time until–
(A) his mental condition is so improved that trial may proceed, if the court finds that there is a
substantial probability that within such additional period of time he will attain the capacity to permit
the proceedings to go forward; or
(B) the pending charges against him are disposed of according to law;
whichever is earlier.
If, at the end of the time period specified, it is determined that the defendant’s mental condition has
not so improved as to permit proceedings to go forward, the defendant is subject to the provisions of
sections 4246 and 4248.
18 U.S.C. § 4241(d).
No. 07-5592 United States v. Payne Page 3
While at Springfield, he underwent psychiatric evaluation by Dr. David Mrad, with medical
consultation by Dr. Robert Sarrazin. Dr. Mrad is the forensic psychologist at Springfield and is the
primary clinician responsible for defendant’s treatment, having observed and evaluated defendant
since May 2004. Dr. Sarrazin is the chief of psychiatry at Springfield and consults with Dr. Mrad
on defendant’s case. Dr. Mrad diagnosed defendant with schizophrenia.
In November 2005, the medical staff at Springfield noticed a deterioration in defendant’s
condition. He began to withdraw, refused to communicate with medical staff, and would not eat.
Defendant’s behavior also became more aggressive and erratic; several times he threw food trays
at prison guards and resisted attempts to take blood samples. As a result, Doctors Mrad and Sarrazin
concluded that defendant’s mental illness, unless treated with medication, would endanger himself
and others. Because defendant would not voluntarily take medication, medical staff involuntarily
injected him with 100 milligrams of haloperidol mixed with two other secondary drugs.
Emergency, involuntary medical treatment without a prior hearing is authorized by 28 C.F.R.
§ 549.43(b). However, ongoing psychiatric medication requires a due process hearing under 28
C.F.R. § 549.43(a). Such a hearing was conducted by the Springfield administration on December
19, 2005. At its conclusion, the medical staff determined that continued involuntary medication was
necessary for the safety of defendant and others. Defendant was alerted of his opportunity to appeal
the hearing decision, but declined to do so.
Medical staff continued to administer haloperidol by injection due to defendant’s continuous
refusal to take oral medication. Defendant’s health and medical condition improved, and he became
more communicative with staff and cooperative in assessing his mental and physical health needs.
However, though defendant has been continually medicated at the current dosage of 150 milligrams
of haloperidol, according to Dr. Mrad, he remains incompetent to stand trial.
On May 10, 2006, defendant moved for an evidentiary hearing as to the propriety of
continued involuntary medication. The motion was granted, defendant underwent further psychiatric
evaluations, and the hearing was held on August 15, 2006.
II.
“We review for clear error the district court’s findings of fact and we review de novo the
district court’s conclusions of law.” Univ. Hosps. v. S. Lorain Merchs. Ass’n Health & Welfare
Benefit Plan & Trust, 441 F.3d 430, 433 (6th Cir. 2006) (citing Anderson v. Int’l Union, United
Plant Guard Workers of Am., 370 F.3d 542, 551 (6th Cir. 2004)).
Defendant challenges the district court’s finding that the proposed drug treatment is
substantially likely to render him competent to stand trial. Since this is a factual finding, we review
for clear error. Id.; accord United States v. Gomes, 387 F.3d 157, 160 (2d Cir. 2004); United States
v. Bradley, 417 F.3d 1107, 1113-14 (10th Cir. 2005).
A. Involuntary Medication of an Inmate
The government may involuntarily administer anti-psychotic drugs to a mentally ill
defendant “if the inmate is dangerous to himself or others and the treatment is in the inmate’s
medical interest.” Washington v. Harper, 494 U.S. 210, 227 (1990). However, “‘[t]he forcible
injection of medication into a nonconsenting person’s body,’ [the Court] said, ‘represents a
substantial interference with that person’s liberty.’” Riggins v. Nevada, 504 U.S. 127, 134 (1992)
(quoting Harper, 494 U.S. at 229). The Riggins Court further suggested that while “forcing
No. 07-5592 United States v. Payne Page 4
antipsychotic drugs on a . . . prisoner is impermissible absent a finding of overriding justification,”
it may be constitutionally permissible to medicate a defendant involuntarily to render him competent
to stand trial. Id. at 135-36.
In Sell v. United States, 539 U.S. 166, 179 (2003), the Supreme Court confirmed that the
government may indeed constitutionally administer anti-psychotic medication involuntarily for the
purpose of rendering a defendant competent to stand trial. Under Sell, such forced medication for
the purpose of restoring competency is permissible if the government establishes that: (1) important
government interests are at stake; (2) involuntary medication is substantially likely to render the
defendant competent to stand trial and substantially unlikely to have side effects that will interfere
significantly with the defendant’s ability to assist counsel at trial; (3) involuntary medication is
necessary to further the government’s interests, and less intrusive means are unlikely to achieve
substantially the same results; and (4) the administration of the drugs is medically appropriate. Id.
at 180-82.
B. Evidentiary Standard
The Supreme Court did not explicitly state the evidentiary standard to be used by trial courts
in evaluating the Sell criteria. Other circuits, in similar circumstances, have required the government
to establish the Sell factors by clear and convincing evidence. See, e.g., Gomes, 387 F.3d at 160
(adopting clear and convincing standard); Bradley, 417 F.3d at 1114 (same). Prior to Sell, this court
also required that the government prove by clear and convincing evidence that forced medication
for the purpose of restoring competency was necessary. See United States v. Brandon, 158 F.3d 947,
961 (6th Cir. 1998). This circuit has recently employed this standard. See United States v. Green,
532 F.3d 538, 545 (6th Cir. 2008). To the extent any question remains about the applicable
standard, we reaffirm that “the risk of error and possible harm involved in deciding whether to
forcibly medicate” for the purpose of restoring competency are “so substantial as to require the
government to prove its case by clear and convincing evidence.” Brandon, 158 F.3d at 961.
III.
On appeal, defendant asserts that the district court erred in finding that the evidence offered
at the hearing is sufficient to establish the second Sell factor—that the proposed treatment is
substantially likely to restore his competency.
Several doctors testified at the hearing, and forensic psychiatric reports prepared by Dr. Mrad
were entered as exhibits. Dr. Mrad testified about the reports, and gave his opinion that defendant
suffers from schizophrenia, and remains incompetent to stand trial. Dr. Mrad went on to
characterize schizophrenia as a serious mental illness, with symptoms including delusions,
disorganized thinking, loose associations, and flat affect. According to Dr. Mrad, defendant has
exhibited these symptoms since his time at Springfield began in 2004, and the symptoms are
consistent with prior forensic reports dating back to 1997.
Dr. Mrad testified that he is not certain that defendant, by continuing the current treatment
of 150 milligram injections of haloperidol, would improve much more than he already has since he
had been on this medicine and dosage for several months. The doctor did, however, state that
Dr. Sarrazin, as the medication consultant, would have a better sense of the likelihood that
continuing defendant’s medication regimen would restore competency.
For his part, Dr. Sarrazin testified that, while he was uncertain as to whether competency
could be restored with haloperidol alone, he believed that there was a substantial probability that the
use of anti-psychotic drugs in addition to haloperidol would restore defendant to competency. Based
on defendant’s improvement since being involuntarily medicated, Dr. Sarrazin stated that, in his
opinion, there was a substantial probability that by taking increased dosages of medication, changing
No. 07-5592 United States v. Payne Page 5
medications, and having adjustments to the medications made when necessary, defendant would
attain competency.
Dr. Sarrazin cautioned that side effects of this increased dosage could include shakiness,
feelings of stiffness in joints and muscles, and acathisia, which is characterized by a feeling that
one’s feet must keep moving. Generally, as the dose of medication increases, the likelihood of the
above side effects increases as well. As of the time of the hearing, however, defendant refused to
take medicines to mitigate side-effects from haloperidol. Because of this, Dr. Sarrazin warned that
increasing the haloperidol dosage might be restricted if defendant experienced these side-effects.
The district court was sensitive to defendant’s significant liberty interests. Accordingly, the
order included several restrictions on the authorized treatment effort to restore competency. They
included the following: (1) limiting treatment to four months; (2) requiring medical staff to request
defendant take the medication orally before each injection, and explain potential side-effects; (3)
requiring close monitoring of defendant’s health, with the understanding that treatment should stop
in the face of major side-effects or other problems, and a report made to the court; (4) requiring
detailed reports to the court at six week intervals including progress towards competency, and any
side-effects experienced.
Defendant argues that the second Sell factor was not met because Drs. Mrad and Sarrazin
admitted that they were not certain that the proposed treatment plan would restore competency. This
argument is not persuasive. The standard is not certainty, but rather substantial probability. The
uncontroverted expert testimony was that the proposed treatment plan was substantially likely to
restore competency without unmanageable side effects. The district court’s decision to credit this
testimony was not clearly erroneous.
IV.
The district court’s order authorizing the treatment plan designed to restore defendant’s
competency to stand trial is affirmed.